Cornerstone Advisors (Washington)’s Charles River Laboratories CRL Stock Holding History

Cornerstone Advisors (Washington)’s Portfolio CRL Stock Details CRL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q3	$17K	Hold	76	–	–	﹤0.01%	386
2020 Q2	$13K	Sell	76 -15	-16%	-$2.39K	﹤0.01%	410
2020 Q1	$11K	Buy	91 +20	+28%	+$3K	﹤0.01%	405
2019 Q4	$11K	Sell	71 -8	-10%	-$1.11K	﹤0.01%	404
2019 Q3	$10K	Buy	79 +26	+49%	+$3.49K	﹤0.01%	411
2019 Q2	$8K	Buy	53 +37	+231%	+$5.02K	﹤0.01%	832
2019 Q1	$2K	Buy	16 +6	+60%	+$788	﹤0.01%	987
2018 Q4	$1K	Hold	10	–	–	﹤0.01%	955
2018 Q3	$1K	Hold	10	–	–	﹤0.01%	973
2018 Q2	$1K	Hold	10	–	–	﹤0.01%	950
2018 Q1	$1K	Buy	+10	New	+$1.08K	﹤0.01%	933
2014 Q3	–	Sell	-10	Closed	-$1K	–	603
2014 Q2	$1K	Hold	10	–	–	﹤0.01%	554
2014 Q1	$1K	Buy	+10	New	+$583	﹤0.01%	462

Other funds holding CRL

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Kayne Anderson Rudnick Investment Management Los Angeles, California $34B AUM 6.31% 1-Year Est. Return

Brown Advisory Baltimore, Maryland $60.9B AUM 15.24% 1-Year Est. Return

Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Cornerstone Advisors (Washington)'s CRL Position: Q3 2020 in Review

Cornerstone Advisors (Washington) held its Charles River Laboratories (CRL) position steady in Q3 2020 at 76 shares worth $17K. The position accounts for ﹤0.01% of the portfolio, ranked #386.

Cornerstone Advisors (Washington) first reported a position in CRL in Q1 2014 and has held it in 13 quarters since. 492 funds tracked by Wall St. Rank hold CRL as of Q3 2020.

Cornerstone Advisors (Washington) held 76 shares of Charles River Laboratories worth $17K as of Q3 2020.
Cornerstone Advisors (Washington) left its Charles River Laboratories share count unchanged in Q3 2020.
Charles River Laboratories made up ﹤0.01% of Cornerstone Advisors (Washington)'s portfolio in Q3 2020, its #386 holding.
Cornerstone Advisors (Washington) first reported a position in Charles River Laboratories in Q1 2014 and has held it in 13 quarters since.
492 funds tracked by Wall St. Rank held Charles River Laboratories as of Q3 2020.

Based on Cornerstone Advisors (Washington)'s 13F filing for Q3 2020, filed 20 Oct 2020.